These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23670570)

  • 21. Local progression after radiofrequency ablation for pulmonary metastases.
    von Meyenfeldt EM; Prevoo W; Peyrot D; Lai A Fat N; Burgers SJ; Wouters MW; Klomp HM
    Cancer; 2011 Aug; 117(16):3781-7. PubMed ID: 21319158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term results of percutaneous radiofrequency ablation of pulmonary metastases: a single institution experience.
    Fanucchi O; Ambrogi MC; Aprile V; Cioni R; Cappelli C; Melfi F; Massimetti G; Mussi A
    Interact Cardiovasc Thorac Surg; 2016 Jul; 23(1):57-64. PubMed ID: 27059068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach".
    Livraghi T; Solbiati L; Meloni F; Ierace T; Goldberg SN; Gazelle GS
    Cancer; 2003 Jun; 97(12):3027-35. PubMed ID: 12784338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.
    Simon CJ; Dupuy DE; DiPetrillo TA; Safran HP; Grieco CA; Ng T; Mayo-Smith WW
    Radiology; 2007 Apr; 243(1):268-75. PubMed ID: 17392258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiofrequency ablation of pulmonary metastases from sarcoma: single-center retrospective evaluation of 46 patients.
    Sato T; Iguchi T; Hiraki T; Gobara H; Fujiwara H; Sakurai J; Matsui Y; Mitsuhashi T; Soh J; Toyooka S; Kanazawa S
    Jpn J Radiol; 2017 Feb; 35(2):61-67. PubMed ID: 27864664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereotactic body radiation therapy for lung metastases from soft tissue sarcoma.
    Navarria P; Ascolese AM; Cozzi L; Tomatis S; D'Agostino GR; De Rose F; De Sanctis R; Marrari A; Santoro A; Fogliata A; Cariboni U; Alloisio M; Quagliuolo V; Scorsetti M
    Eur J Cancer; 2015 Mar; 51(5):668-74. PubMed ID: 25686482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases.
    de Baère T; Aupérin A; Deschamps F; Chevallier P; Gaubert Y; Boige V; Fonck M; Escudier B; Palussiére J
    Ann Oncol; 2015 May; 26(5):987-991. PubMed ID: 25688058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extending indications for radiofrequency ablation of lung tumors through an intraoperative approach.
    Linden PA; Wee JO; Jaklitsch MT; Colson YL
    Ann Thorac Surg; 2008 Feb; 85(2):420-3. PubMed ID: 18222236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Radiofrequency ablation (RFA) of lung metastases from colorectal cancer (CRC)-one-year follow-up].
    Steinke K; King J; Glenn D; Morris DL
    Radiologe; 2004 Jul; 44(7):687-92. PubMed ID: 15232689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
    Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
    Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous radiofrequency thermal ablation in the management of lung tumors: presentation of clinical experience on a series of 35 patients.
    Thanos L; Mylona S; Ptohis N; Tsiouris S; Sotiropoulou E; Pomoni A; Pomoni M
    Diagn Interv Radiol; 2009 Dec; 15(4):290-6. PubMed ID: 19813168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation.
    Beland MD; Wasser EJ; Mayo-Smith WW; Dupuy DE
    Radiology; 2010 Jan; 254(1):301-7. PubMed ID: 20032160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
    Forauer AR; Dewey BJ; Seigne JD
    Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiographic Local Tumor Control and Pain Palliation of Sarcoma Metastases within the Musculoskeletal System with Percutaneous Thermal Ablation.
    Vaswani D; Wallace AN; Eiswirth PS; Madaelil TP; Chang RO; Tomasian A; Jennings JW
    Cardiovasc Intervent Radiol; 2018 Aug; 41(8):1223-1232. PubMed ID: 29541840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with actual long-term survival following soft tissue sarcoma pulmonary metastasectomy.
    Smith R; Pak Y; Kraybill W; Kane JM
    Eur J Surg Oncol; 2009 Apr; 35(4):356-61. PubMed ID: 18294807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors for occurrence of local tumor progression after percutaneous radiofrequency ablation for lung neoplasms.
    Yamagami T; Kato T; Hirota T; Yoshimatsu R; Matsumoto T; Shimada J; Nishimura T
    Diagn Interv Radiol; 2007 Dec; 13(4):199-203. PubMed ID: 18092293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percutaneous radiofrequency ablation of lung cancer presenting as ground-glass opacity.
    Iguchi T; Hiraki T; Gobara H; Fujiwara H; Matsui Y; Soh J; Toyooka S; Kiura K; Kanazawa S
    Cardiovasc Intervent Radiol; 2015 Apr; 38(2):409-15. PubMed ID: 24938905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Five-year survival following radiofrequency ablation of small, solitary, hepatic colorectal metastases.
    Gillams AR; Lees WR
    J Vasc Interv Radiol; 2008 May; 19(5):712-7. PubMed ID: 18440460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative survival analysis in patients with pulmonary metastases from nasopharyngeal carcinoma treated with radiofrequency ablation.
    Pan CC; Wu PH; Yu JR; Li W; Huang ZL; Wang JP; Zhao M
    Eur J Radiol; 2012 Apr; 81(4):e473-7. PubMed ID: 21700408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous radiofrequency ablation for unresectable pulmonary metastases from renal cell carcinoma.
    Soga N; Yamakado K; Gohara H; Takaki H; Hiraki T; Yamada T; Arima K; Takeda K; Kanazawa S; Sugimura Y
    BJU Int; 2009 Sep; 104(6):790-4. PubMed ID: 19338555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.